In ERBB2-positive metastatic #BreastCancer, first-line treatment is shifting beyond taxane-based induction toward newer regimens and expanded maintenance options that may change treatment sequencing and duration. ja.ma/3UHbgqv
JAMA Oncology
@JAMAOnc
JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
506 Following 51K Followers 19K Posts
Latest posts 5
Among trainees providing #CancerCare, representation of physicians from groups underrepresented in medicine increased after 2020, but still did not match the diversity of the general US population in 2025. ja.ma/4zoqO1l
In 2027, JAMA will convene leaders across #medicine, research, #technology, industry, and #policy to address how #AI will reshape health care and biomedical science.
Learn more: ja.ma/4kAk3oA
#HealthAfterAI #JAMASummit
Learn more: ja.ma/4kAk3oA
#HealthAfterAI #JAMASummit
0:30
馃摑 JAMA Oncology Patient Page: Supplements and Wellness Products During #Cancer Care This Patient Page discusses safety when taking supplements and wellness products during cancer treatment. ja.ma/3W97574
A 79-year-old woman with high-risk myelodysplastic syndrome treated with 5-azacitidine presented with painful ulcers on the tongue and right lower extremity. What is your diagnosis? ja.ma/4B6SpW4